Results 201 to 210 of about 45,700 (234)
Some of the next articles are maybe not open access.
Biochemistry, 1999
The sulfhydryl groups of the three cysteines in bovine arrestin react with DTNB very slowly (over a period of several hours). In the presence of the synthetic phosphopeptide comprising the fully phosphorylated carboxyl-terminal 19 amino acids of bovine rhodopsin, the reactivity of one of the sulfhydryls was enhanced while that of another was greatly ...
J H, McDowell +6 more
openaire +2 more sources
The sulfhydryl groups of the three cysteines in bovine arrestin react with DTNB very slowly (over a period of several hours). In the presence of the synthetic phosphopeptide comprising the fully phosphorylated carboxyl-terminal 19 amino acids of bovine rhodopsin, the reactivity of one of the sulfhydryls was enhanced while that of another was greatly ...
J H, McDowell +6 more
openaire +2 more sources
Arrestin Regulation of Small GTPases
2013The regulation of small GTPases by arrestins is a relatively new way by which arrestin can exert influence over cell signalling cascades, hence, molecular interactions and specific binding partners are still being discovered. A pathway showcasing the regulation of GTPase activity by β-arrestin was first elucidated in 2001.
Ryan T, Cameron, George S, Baillie
openaire +2 more sources
Quantifying Biased β-Arrestin Signaling
2013It is now established that agonists do not uniformly activate pleiotropic signaling mechanisms initiated by receptors but rather can bias signals according to the unique receptor conformations they stabilize. One of the important emerging signaling systems where this can occur is through β-arrestin.
openaire +2 more sources
Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics
Cell, 2022John Janetzko, Brian K Kobilka
exaly
Plasma membrane preassociation drives β-arrestin coupling to receptors and activation
Cell, 2023Davide Calebiro
exaly
GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision
Cell, 2022Wesley B Asher +2 more
exaly
Arrestin Pathways as Drug Targets
2013Our growing appreciation of the pluridimensionality of G protein-coupled receptor (GPCR) efficacy, coupled with the phenomenon of orthosteric ligand "bias," offers the prospect of drugs that selectively modulate different aspects of GPCR function for therapeutic benefit.
openaire +2 more sources

